First look: how a new drug moves through the body

NCT ID NCT07247357

Summary

This early-stage study aimed to understand how the experimental drug LY4064809 is absorbed and eliminated by the body. It involved 10 healthy Chinese adults who took the drug orally and were monitored for about 21 days. The main goals were to measure drug levels in the blood and check for safety and tolerability.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Lilly Centre for Clinical Pharmacology

    Singapore, 138623, Singapore

Conditions

Explore the condition pages connected to this study.